These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9920102)

  • 21. [The studies of melatonin values in the cerebrospinal fluid of hydrocephalic patients].
    Kurisaka M; Miyake H; Eghwrudjakpor PO; Mori K
    No To Shinkei; 1991 Jul; 43(7):631-6. PubMed ID: 1910947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease.
    Wu YH; Zhou JN; Van Heerikhuize J; Jockers R; Swaab DF
    Neurobiol Aging; 2007 Aug; 28(8):1239-47. PubMed ID: 16837102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbated CSF abnormalities in younger patients with Alzheimer's disease.
    Dumurgier J; Gabelle A; Vercruysse O; Bombois S; Laplanche JL; Peoc'h K; Schraen S; Sablonnière B; Pasquier F; Touchon J; Lehmann S; Hugon J; Paquet C
    Neurobiol Dis; 2013 Jun; 54():486-91. PubMed ID: 23416172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
    Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
    J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
    Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
    J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 22(4):1223-30. PubMed ID: 20930303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm.
    Reiter RJ; Sharma R; Cucielo MS; Tan DX; Rosales-Corral S; Gancitano G; de Almeida Chuffa LG
    Cell Mol Life Sci; 2023 Mar; 80(4):88. PubMed ID: 36917314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease.
    Motawaj M; Peoc'h K; Callebert J; Arrang JM
    J Alzheimers Dis; 2010; 22(3):861-71. PubMed ID: 20858978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
    Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
    Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocretin (orexin) loss in Alzheimer's disease.
    Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
    Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
    Merched A; Blain H; Visvikis S; Herbeth B; Jeandel C; Siest G
    J Neurol Sci; 1997 Jan; 145(1):33-9. PubMed ID: 9073026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
    Merched A; Serot JM; Visvikis S; Aguillon D; Faure G; Siest G
    FEBS Lett; 1998 Mar; 425(2):225-8. PubMed ID: 9559653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin enters the cerebrospinal fluid through the pineal recess.
    Tricoire H; Locatelli A; Chemineau P; Malpaux B
    Endocrinology; 2002 Jan; 143(1):84-90. PubMed ID: 11751596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.
    Song H; Saito K; Seishima M; Noma A; Urakami K; Nakashima K
    Neurosci Lett; 1997 Aug; 231(3):175-8. PubMed ID: 9300650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in nocturnal serum melatonin levels in humans with growth and aging.
    Waldhauser F; Weiszenbacher G; Tatzer E; Gisinger B; Waldhauser M; Schemper M; Frisch H
    J Clin Endocrinol Metab; 1988 Mar; 66(3):648-52. PubMed ID: 3350912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential cerebrospinal fluid and plasma sampling in humans: 24-hour melatonin measurements in normal subjects and after peripheral sympathectomy.
    Bruce J; Tamarkin L; Riedel C; Markey S; Oldfield E
    J Clin Endocrinol Metab; 1991 Apr; 72(4):819-23. PubMed ID: 2005207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative CSF Melatonin Concentrations and the Occurrence of Delirium in Older Hip Fracture Patients: A Preliminary Study.
    Scholtens RM; de Rooij SE; Vellekoop AE; Vrouenraets BC; van Munster BC
    PLoS One; 2016; 11(12):e0167621. PubMed ID: 27936113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Talwar P; Sinha J; Grover S; Agarwal R; Kushwaha S; Srivastava MV; Kukreti R
    J Neurol Sci; 2016 Jan; 360():179-87. PubMed ID: 26723997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.